Detalles de la búsqueda
1.
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 17(12): 1661-1671, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825638
2.
Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).
Breast Cancer Res Treat
; 155(3): 501-12, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868123
3.
Disentangling acceptance: Direct and indirect effects of partner acceptance on felt acceptance and relationship satisfaction.
J Fam Psychol
; 36(3): 378-384, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34197160
4.
Erratum: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).
Breast Cancer Res Treat
; 157(2): 403, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27167985
5.
Associations between mother-infant bed-sharing practices and infant affect and behavior during the still-face paradigm.
Infant Behav Dev
; 60: 101464, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32650137
6.
The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Biol Blood Marrow Transplant
; 13(4): 486-92, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17382255
Resultados
1 -
6
de 6
1
Próxima >
>>